• HOME • SERVICES • PRODUCTS • COMPANY • NEWS • CONTACT • PARTNERS • FAQ • SEARCH  

 

QUICK LINKS
 
bullet Diagnostics
bullet Clinical Diagnostics
bullet Instant Check
bullet Cytoactiv
bullet Bionexia HCG-Combo
bullet Bionexia Strep A Ratio
bullet Bionexia ph-Balance
bullet Bionexia Streptokokken A
bullet Bionexia Streptokokken B
bullet Bionexia Hb/Hp Complex
bullet Bionexia FOBplus
bullet Bionexia Chlamydia Antigen
bullet

Life Science

bullet

Antibodies

bullet Biological Enzyme Pyrolase
bullet Blot
bullet Cellkines
bullet Clinical Specimens
bullet Custom Panels
bullet Drug Discovery
bullet Elisa
bullet Microbiology & Biochemistry
bullet NATtrol
bullet Oxidative Stress
bullet Seroconversion Panels
bullet Support Reagents
bullet Viral Lysates
bullet Instrumentation
bullet  AUTOBLOT 3000


 
 

MONOBODIES
(Monoclonal Antibodies)


Monoclonal Antibodies are powerful immunochemical tools useful in a variety of applications including ELISA, immunoblotting and immuno-histochemistry.  They offer tremendous advantages over polyclonal antibodies because of their characteristics of homogeneity and specificity of binding.

 

  • Reactive against antigens from HIV-1, HTLV-1 and HTLV-II

  • Available in 100 ug and 1mg sizes

  • Multiple clones available for most antigen targets

 

Monoclonal Antibody Reactivity Chart

Click here for references on ZMC's Monoclonal Antibodies

 

 


Anti-HIV-1

p17
CLONE 2D11

CATALOG #0801076 (100 µg)
CATALOG # 0801122 (1 mg)

p17
CLONE 32/1.24.89

CATALOG #0801077 (100 µg)
CATALOG #0801115 (1 mg)

p17
CLONE 32/5.8.42

CATALOG # 0801005
(100 µg)
CATALOG # 0801123 (1 mg)

p24
CLONE 38/8.7.47

CATALOG # 0801004 (100 µg)
CATALOG # 0801125 (1 mg)

p24
CLONE
32/5.17.76
CATALOG # 0801078 (100 µg)
CATALOG # 0801124

p24
CLONE
39/5.1.23
CATALOG #0801079 (100 µg)
CATALOG #0801126 (1 mg)

p24
CLONE
39/5.4A
CATALOG #0801080 (100 µg)
CATALOG #0801136 (1 mg)

p24
CLONE
39/6.14
CATALOG #0801081 (100 µg)
CATALOG #0802014 (1 mg)

gp41
CLONE 10E9

CATALOG #0801006 (100 µg)
CATALOG #0801121 (1 mg)

RT
CLONE
39/4.12.2
CATALOG #0801007 (100 µg)
CATALOG #0801128 (1 mg)

Anti-HTLV-I

p19
CLONE
45/6.11.1.3
CATALOG #0801082
(100 µg)
CATALOG # 0801108
(1 mg)

p19
CLONE
TP-7
CATALOG #0801003 (100 µg)
CATALOG # 0801107
(1 mg)

p24
CLONE
46/3.24.4
CATALOG #0801018 (100 µg)
CATALOG # 0801110
(1 mg)

gp46
CLONE
67/5.5.13.1
CATALOG #0801084
(100 µg)
CATALOG # 0801127
(1 mg)

gp46
CLONE 68/4.11.21

CATALOG #0801085 (100 µg)
CATALOG # 0801118
(1 mg)

gp46
CLONE
65/6C2.2.34
CATALOG #0802004 (100 µg)
CATALOG # 0801094
(1 mg)

Anti-HTLV-II

p19
CLONE 78/6.18.07

CATALOG #0801093
(100 µg)
CATALOG # 0801113
(1 mg)

p24
CLONE 75/4.21.11

CATALOG #0801087 (100 µg)
CATALOG # 0801120
(1 mg)

gp46
CLONE
73/4.9.8
CATALOG #0801086 (100 µg)
CATALOG # 0801119
(1 mg)

 

Do you want a quotation? 
Send an e-mail to enquiries@helveticahealthcare.com

Do you have a question regarding your invoice or payment instructions?
Send an e-mail to accounts@helveticahealthcare.com

You are already our customer and you would like to place an order?
Send an e-mail to sales@helveticahealthcare.com

You have a technical question regarding our products or need help to find the product you need?
Send an e-mail to
technical@helveticahealthcare.com
 

or

 

send us your request by filling the below form.

 

Your message

Category of request

Your details

Name
Job position
Company
Address
Phone
Fax
E-mail

 

 

CONTACT US:

 

HHC - Switzerland & Worldwide

sales@helveticahealthcare.com

Tel +41 (0)22 788 8812
Tel +41 (0)22 534 9454
Fax +41 (0) 22 594 8507

HHC - Deutschland
deutschland@helveticahealthcare.com

Tel +49 (0)89 2351 9958

 

 

 

 

 

 

NEWS

HHC TV is now available!

HHC is pleased to announce that a specific youtube page is now available. This page will be implemented in the next months and furnished with short movies presenting our products and relevant scientific news.
HHC TV link
HHC in association with Nucleon Ltd is taking part to the 20th UICC World Cancer Congress from 27 to 31 Auust 2008 in Geneva. Through our presence (stand n°1116) we will promote the advantages and benefits of using Cytoactiv the first prognostic marker for cervical dysplasia.



Copyright © 2007 - Helvetica Health Care Sàrl - Last update October 2008